1P-LSD in Bosnia and Herzegovina: not individually verified
We have not confirmed that 1P-LSD specifically is scheduled in Bosnia and Herzegovina, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.
- What is on record
- Not confirmed. The search made here used the Latin identifier 1p-lsd and returned no entry and no near entry. The list does reach lysergide, under the Bosnian name lizergid, but that entry prints no derivative or prodrug limb, so nothing in the text read carries a substituted lysergamide into it. The reading that produced this was made against the list attached to the 2006 Law, as consolidated through Official Gazette 56/26 with the remifentanil move at 58/26, read as at 20 September 2026, and reading it on that date does not rule out a later amendment, so this is an unresolved search result and not a finding that the substance is outside the list.
Confirm directly with Bosnia and Herzegovina’s national drug authority or your own embassy before you rely on anything.
What Bosnia and Herzegovina HAS confirmed for related substances
This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.
Before you travel
Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulate in the destination immediately, not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →